Search results
Showing 1021 to 1035 of 2026 results for nice guidelines
NICE has developed a medtech innovation briefing (MIB) on PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection .
Processes and methods for NICE-wide guidance surveillance (PMG49)
This guide describes the methods and processes that NICE follows to assess the impact of new evidence, changes to the health and care system, or other new, relevant information that has come to light after NICE guidance has published
NICE has developed a medtech innovation briefing (MIB) on Thora 3Di for assessing asthma in children .
NICE's guidance executive is made up of executive directors, guidance centre directors and senior team members.
urinary incontinence, see NICE's decision aid on treating complications from mesh used for stress urinary incontinence...
pelvic organ prolapse, see NICE's decision aid on treating complications from mesh used for pelvic organ prolapse...
Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes (TA390)
Evidence-based recommendations on canagliflozin (Invokana), dapagliflozin (Forxiga) and empagliflozin (Jardiance) as options for treating type 2 diabetes in adults.
Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (HTG438)
Evidence-based recommendations on virtual chromoendoscopy (VCE) using NBI, FICE or i-scan to assess colorectal polyps of 5 mm or less during colonoscopy.
Kendall DL for ECG monitoring in people having cardiac surgery (MIB177)
NICE has developed a medtech innovation briefing (MIB) on Kendall DL for ECG monitoring in people having cardiac surgery .
Agenda and papers of the NICE public board meeting on 19 July 2023
Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers (HTG495)
Evidence-based recommendations on Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers.
This guideline covers alcohol problems among people over 10. It aims to prevent and identify such problems as early as possible using a mix of policy and practice.
Day-to-day decision making is the responsibility of NICE's executive team.
Evidence-based recommendations on Memokath 051 Ureter stent for ureteric obstruction.
Discontinued Reference number: GID-NG10163